img

Global Typhoid Vi Polysaccharide Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Typhoid Vi Polysaccharide Vaccine Market Research Report 2024

Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older.
According to Mr Accuracy reports new survey, global Typhoid Vi Polysaccharide Vaccine market is projected to reach US$ 741.3 million in 2029, increasing from US$ 524 million in 2022, with the CAGR of 5.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Typhoid Vi Polysaccharide Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Typhoid Vi Polysaccharide Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi Pasteur SA
GSK
Emergent BioSolutions
Segment by Type
Child
Adult

Segment by Application


Government Institution
Private Sector
Other

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Typhoid Vi Polysaccharide Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Typhoid Vi Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of Typhoid Vi Polysaccharide Vaccine
1.2 Typhoid Vi Polysaccharide Vaccine Segment by Type
1.2.1 Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Child
1.2.3 Adult
1.3 Typhoid Vi Polysaccharide Vaccine Segment by Application
1.3.1 Global Typhoid Vi Polysaccharide Vaccine Market Value by Application: (2024-2034)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Typhoid Vi Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Typhoid Vi Polysaccharide Vaccine Revenue 2018-2029
1.4.2 Global Typhoid Vi Polysaccharide Vaccine Sales 2018-2029
1.4.3 Global Typhoid Vi Polysaccharide Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Typhoid Vi Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Typhoid Vi Polysaccharide Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Typhoid Vi Polysaccharide Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Product Type & Application
2.7 Typhoid Vi Polysaccharide Vaccine Market Competitive Situation and Trends
2.7.1 Typhoid Vi Polysaccharide Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Typhoid Vi Polysaccharide Vaccine Players Market Share by Revenue
2.7.3 Global Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Typhoid Vi Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global Typhoid Vi Polysaccharide Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Typhoid Vi Polysaccharide Vaccine Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2018-2029
3.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2018-2024
3.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2024-2029
3.3 Global Typhoid Vi Polysaccharide Vaccine Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2018-2029
3.3.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2018-2024
3.3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2024-2029
3.4 North America Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2029)
3.4.3 North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2029)
3.5.3 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2018-2029)
4.1.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2018-2024)
4.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2024-2029)
4.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2018-2029)
4.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2018-2024)
4.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2024-2029)
4.2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Typhoid Vi Polysaccharide Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2018-2029)
5.1.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2018-2024)
5.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2024-2029)
5.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2018-2029)
5.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2018-2024)
5.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2024-2029)
5.2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Typhoid Vi Polysaccharide Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi Pasteur SA
6.1.1 Sanofi Pasteur SA Corporation Information
6.1.2 Sanofi Pasteur SA Description and Business Overview
6.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolio
6.1.5 Sanofi Pasteur SA Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 GSK Typhoid Vi Polysaccharide Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Emergent BioSolutions
6.3.1 Emergent BioSolutions Corporation Information
6.3.2 Emergent BioSolutions Description and Business Overview
6.3.3 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolio
6.3.5 Emergent BioSolutions Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Typhoid Vi Polysaccharide Vaccine Industry Chain Analysis
7.2 Typhoid Vi Polysaccharide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Typhoid Vi Polysaccharide Vaccine Production Mode & Process
7.4 Typhoid Vi Polysaccharide Vaccine Sales and Marketing
7.4.1 Typhoid Vi Polysaccharide Vaccine Sales Channels
7.4.2 Typhoid Vi Polysaccharide Vaccine Distributors
7.5 Typhoid Vi Polysaccharide Vaccine Customers
8 Typhoid Vi Polysaccharide Vaccine Market Dynamics
8.1 Typhoid Vi Polysaccharide Vaccine Industry Trends
8.2 Typhoid Vi Polysaccharide Vaccine Market Drivers
8.3 Typhoid Vi Polysaccharide Vaccine Market Challenges
8.4 Typhoid Vi Polysaccharide Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Typhoid Vi Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Typhoid Vi Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Typhoid Vi Polysaccharide Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Typhoid Vi Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Vi Polysaccharide Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Typhoid Vi Polysaccharide Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Type (2018-2024)
Table 59. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Type (2024-2029)
Table 60. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Application (2018-2024)
Table 69. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Application (2024-2029)
Table 70. Sanofi Pasteur SA Corporation Information
Table 71. Sanofi Pasteur SA Description and Business Overview
Table 72. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product
Table 74. Sanofi Pasteur SA Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. GSK Typhoid Vi Polysaccharide Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Emergent BioSolutions Corporation Information
Table 81. Emergent BioSolutions Description and Business Overview
Table 82. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product
Table 84. Emergent BioSolutions Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Typhoid Vi Polysaccharide Vaccine Distributors List
Table 88. Typhoid Vi Polysaccharide Vaccine Customers List
Table 89. Typhoid Vi Polysaccharide Vaccine Market Trends
Table 90. Typhoid Vi Polysaccharide Vaccine Market Drivers
Table 91. Typhoid Vi Polysaccharide Vaccine Market Challenges
Table 92. Typhoid Vi Polysaccharide Vaccine Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Typhoid Vi Polysaccharide Vaccine
Figure 2. Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Typhoid Vi Polysaccharide Vaccine Market Share by Type in 2022 & 2029
Figure 4. Child Product Picture
Figure 5. Adult Product Picture
Figure 6. Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Typhoid Vi Polysaccharide Vaccine Market Share by Application in 2022 & 2029
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Global Typhoid Vi Polysaccharide Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Typhoid Vi Polysaccharide Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Typhoid Vi Polysaccharide Vaccine Sales (2018-2029) & (K Units)
Figure 14. Global Typhoid Vi Polysaccharide Vaccine Average Price (USD/Unit) & (2018-2029)
Figure 15. Typhoid Vi Polysaccharide Vaccine Report Years Considered
Figure 16. Typhoid Vi Polysaccharide Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Typhoid Vi Polysaccharide Vaccine Players: Market Share by Revenue in 2022
Figure 19. Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Typhoid Vi Polysaccharide Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. the United States Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. UK Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
Figure 44. Latin America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Typhoid Vi Polysaccharide Vaccine by Type (2018-2029)
Figure 54. Global Revenue Market Share of Typhoid Vi Polysaccharide Vaccine by Type (2018-2029)
Figure 55. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Typhoid Vi Polysaccharide Vaccine by Application (2018-2029)
Figure 57. Global Revenue Market Share of Typhoid Vi Polysaccharide Vaccine by Application (2018-2029)
Figure 58. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Application (2018-2029)
Figure 59. Typhoid Vi Polysaccharide Vaccine Value Chain
Figure 60. Typhoid Vi Polysaccharide Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed